RMD Open | Publishes peer-reviewed original research on the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases.

Intro Widget

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

RMD Open is an official journal of EULAR. You can keep up with the latest news via Twitter and Facebook.

Scopus CiteScore: 3.47 (2017)

Editor-in-Chief: Professor Bernard Combe, CHU Lapeyronie, France
Editorial team

Authors

RMD Open considers submissions of a variety of article types, including original articles, short reports and clinical cases.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Published articles are discoverable via PubMed, Scopus and Google Scholar.

Author information

Submit a paper

Intro Widget

Authors

Latest Articles

Rheumatoid arthritis:

Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses

Correction:

Correction: Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors

Systemic sclerosis:

Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis

Rheumatoid arthritis:

Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study

Rheumatoid arthritis:

Associations between antenatal prednisone exposure and long-term cortisol and cortisone concentrations in children born to women with rheumatoid arthritis: results from a nationwide prospective cohort study

Most Read Articles

Psoriatic arthritis:

Distinguishing rheumatoid arthritis from psoriatic arthritis

Rheumatoid arthritis:

Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study

Psoriatic arthritis:

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs

Rheumatoid arthritis:

Don’t neglect nutrition in rheumatoid arthritis!

Imaging:

MR signal intensity: staying on the bright side in MR image interpretation

Altmetrics

Related Journals